AMD, DMO therapy research review
Emerging treatment options for geographic atrophy (GA) secondary to age-related macular degeneration Hannah Khan Clinical Ophthalmology, 2023 Review: This review evaluated the current status of
4 min read
DA
Dr Andrew Riley
2 articles
Ozurdex: one year on
It has been just over a year since Ozurdex, a dexamethasone-sustained release implant, was first funded by Pharmac for diabetic macular oedema (DMO), the most common cause of visual loss in our
5 min read